title: Prostate cancer: Phase I study shows potential of TRC105 in mCRPC.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Kelsey
mesh_terms: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D006801:Humans; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents